Kynam Capital Management, LP

Position in CRBU — Caribou Biosciences, Inc.

CIK 1907884 PRINCETON, NJ

Position in CRBU

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,756,273

+$776,023 QoQ

Shares Held

2,503,302

0.0% QoQ

Ownership

2.52%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

of 137 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Kynam Capital Management, LP holds $1,494,846,229 across 33 Biotechnology names. CRBU ranks #30 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SNDX	Syndax Pharmaceuticals Inc	8,050,959	$188,070,402
2	CLDX	Celldex Therapeutics, Inc.	5,840,567	$185,262,785
3	PCVX	Vaxcyte, Inc.	2,922,335	$169,816,886
4	COGT	Cogent Biosciences, Inc.	4,037,331	$155,396,870
5	VERA	Vera Therapeutics, Inc.	3,398,224	$136,710,551
6	BEAM	Beam Therapeutics Inc.	3,682,185	$87,746,468
7	CTMX	CytomX Therapeutics, Inc.	15,013,093	$70,561,537
8	TVTX	Travere Therapeutics, Inc.	1,569,018	$46,615,524

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,756,273	2,503,302	0.0%	Shares	Sole	2026-05-15
2025-12-31	$3,980,250	2,503,302	-18.4%	Shares	Sole	2026-02-17
2025-09-30	$7,147,913	3,067,774	0.0%	Shares	Sole	2025-11-14
2025-06-30	$3,865,395	3,067,774	-6.2%	Shares	Sole	2025-08-14
2025-03-31	$2,984,731	3,269,147	+35.9%	Shares	Sole	2025-05-15
2024-12-31	$3,825,773	2,406,147	+2.1%	Shares	Sole	2025-02-14
2024-09-30	$4,618,048	2,356,147	+43.1%	Shares	Sole	2024-11-14
2024-06-30	$2,700,591	1,646,702	+54.1%	Shares	Sole	2024-08-14
2024-03-31	$5,492,228	1,068,527	0.0%	Shares	Sole	2024-05-15
2023-12-31	$6,122,659	1,068,527	0.0%	Shares	Sole	2024-02-14
2023-09-30	$5,107,559	1,068,527	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.